U.S. Department of Health and Human Services (DHHS) - Substance Abuse and Mental Health Services Administration (SAMHSA)
05/06/19 11:59 PM ET
Grants to USA state and local government agencies and tribal agencies and organizations for resources and training to enable first responders to administer opioid overdose treatments. Required registrations may take up to six weeks to complete. Rural high-need communities will be given preference.
The purpose of this program is to allow first responders and members of other key community sectors to administer a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose. Recipients will train and provide resources to first responders and members of other key community sectors at the state, tribal, and local governmental levels on carrying and administering a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose. Recipients will also establish processes, protocols, mechanisms for referral to appropriate treatment and recovery communities, and safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs.
For the purposes of this funding opportunity announcement (FOA), first responders include firefighters, law enforcement officers, paramedics, emergency medical technicians, or other legally organized and recognized volunteer organizations that respond to adverse opioid related incidents.
FR-CARA grant funds must be used primarily to support the following activities:
- Make a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act available for emergency treatment of known or suspected opioid overdose available to be carried and administered by first responders and members of other key community sectors;
- Train and provide resources for first responders and members of other key community sectors on carrying and administering a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose;
- Train and provide resources for first responders and members of other key community sectors on safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs to protect themselves from exposure to such drugs and respond appropriately when exposure occurs;
- Establish processes, protocols, and mechanisms for referral to appropriate treatment and recovery communities, and safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs. To facilitate the referral processes, you may hire an outreach coordinator or establish a team to connect individuals receiving opioid overdose reversal drugs to follow-up services; and
- Form or join an established advisory council that meets the requirements of the grant. If you choose to join an established advisory council, you must establish a memorandum of understanding (MOU) with the existing council that ensures that the FR-CARA requirements will be met.
SAMHSA’s FR-CARA grants may also support the following types of activities:
- Collaborate with health care providers to educate them on overdose dangers, and recommend that they consider providing resources to overdose victims and families, including information on treatment and recovery.
- Provide public education on any state “Good Samaritan” laws, such as those that permit bystanders to alert emergency responders to an overdose or to administer FDA-approved overdose reversal drugs without fear of civil or criminal penalties.
For more details on program requirements and expectations, see the FOA: https://www.samhsa.gov/sites/default/files/grants/pdf/fr_cara_3.6.19_0.pdf#page=7
For Communities of High Need selection guidelines, see the FOA: https://www.samhsa.gov/sites/default/files/grants/pdf/fr_cara_3.6.19_0.pdf#page=8
GrantWatch ID#: 185550
Proposed budgets cannot exceed $250,000 - $800,000 in total costs (direct and indirect) in any year of the proposed project.
- States: Up to $800,000
- Local Governmental Entity: Up to $500,000
- Tribe or Tribal Organization: Up to $250,000
A minimum of $9.1 million dollars of the funds available for awards will be dedicated to rural communities of high need.
Anticipated Project Start Date: August 30, 2019
Length of Project Period: Up to 4 years
Annual continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
Eligible applicants are:
- State governments;
- Federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian Organizations, and consortia of tribes or tribal organizations; and
- Local governmental entities including, but not limited to, municipal corporations, counties, cities, boroughs, incorporated towns, and townships.
The eligibility for this grant program is statutorily defined in Section 546 of the Public Health Service Act.
For the definitions of Tribal and Urban Indian Organizations: https://www.samhsa.gov/sites/default/files/grants/pdf/fr_cara_3.6.19_0.pdf#page=13
- No more than 20 percent of the grant award may be used for data collection, performance measurement, and performance assessment expenses.
- Recipients may use up to 10 percent of funds for state, tribal or local governmental level administrative costs.
- SAMHSA grant award funds must not be used for the same activities that are funded by HRSA, CDC, or other SAMHSA programs.
- Only drugs or devices approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose may be purchased with FR-CARA funds.
Applications are due by 11:59 PM (Eastern Time) on May 6, 2019.
Intergovernmental Review (E.O. 12372): Applicants must comply with E.O. 12372 if their state(s) participate(s). Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS)/Single State Agency Coordination: Applicants must send the PHSIS to appropriate state and local health agencies by the application deadline. Comments from the Single State Agency are due no later than 60 days after the application deadline.
SAMHSA’s application procedures have changed. All applicants must register with NIH’s eRA Commons in order to submit an application. This process takes up to six weeks. If you believe you are interested in applying for this opportunity, you MUST start the registration process immediately. Do not wait to start this process.
Applicants also must register with the System for Award Management (SAM) and Grants.gov (see Appendix A for all registration requirements).
Grants.gov is an online portal for submitting federal grant applications. It requires a one-time registration in order to submit applications. While Grants.gov registration is a one-time only registration process, it consists of multiple subregistration processes (i.e., DUNS number and SAM registrations) before you can submit your application. [Note: eRA Commons registration is separate].
You can register to obtain a Grants.gov username and password at http://www.grants.gov/web/grants/register.html.
Applying for a New SAMHSA Grant: https://www.samhsa.gov/grants/applying
Application Forms and Resources: https://www.samhsa.gov/grants/applying/forms-resources
View this opportunity on Grants.gov: https://www.grants.gov/web/grants/view-opportunity.html?oppId=313525
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Grants Management and Budget Issues:
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming